NOBILI, STEFANIA

NOBILI, STEFANIA  

Medicina Sperimentale e Clinica  

Mostra records
Risultati 1 - 20 di 166 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 2012 F. Guidi; M. Puglia; C. Gabbiani; I. Landini; T. Gamberi; D. Fregona; M.A. Cinellu; S. Nobili; E. Mini; L. Bini; P.A. Modesti; A. Modesti; L. Messori
Administering gemcitabine as fixed-dose-rate infusion in combination with cisplatin, potentially effective target plasma concentrations are achieved in patients with advanced non-small cell lung cancer 2007 Marangon E, Sala F, Caffo O, D'Incalci M, Galligioni E, Fallani S, Nobili S, Cassetta M, Mini E, Zucchetti M
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study 2017 Nobili S, Mini, E, Mazzei T, Vannacci A
Analisi dell'espressione di geni coinvolti nella resistenza al 5-fluorouracile nel carcinoma colorettale 2002 Stefania Nobili
Analysis of Gene Expression Profiles Reveals Novel Correlations With the Clinical Course of Colorectal Cancer 2007 D. Cavalieri; P. Dolara; E. Mini; C. Luceri; C. Castagnini; S. Toti; K. Maciag; C. De Filippo; S. Nobili; M. Morganti; C. Napoli; G. Tonini; M. Baccini; A. Biggeri; F. Tonelli; R. Valanzano; C. Orlando; S. Gelmini; F. Cianchi; L. Messerini; L. Luzzatto
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 2018 Magherini, Francesca; Fiaschi, Tania; Valocchia, Elisa; Becatti, Matteo; Pratesi, Alessandro; Marzo, Tiziano; Massai, Lara; Gabbiani, Chiara; Landini, Ida; Nobili, Stefania; Mini, Enrico; Messori, Luigi; Modesti, Alessandra; Gamberi, Tania*
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 2020 Roviello G.; Ramello M.; Catalano M.; D'Angelo A.; Conca R.; Gasperoni S.; Dreoni L.; Petrioli R.; Ianza A.; Nobili S.; Aieta M.; Mini E.
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: a first insight 2016 Garziera, M; Catamo, E; Crovella, S; Montico, M; Cecchin, E; Lonardi, S; Mini, E; Nobili, S; Romanato, L; Toffoli, G
Bimonthly chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients with metastatic colorectal cancer pretreated with CPT11- or OHP-based CHT 2004 Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Checcacci D; Giglioni B; Mazzei T; Mini E
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic Acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. 2008 S. Nobili; D. Checcacci; F. Filippelli; S. Del Buono; V. Mazzocchi; T. Mazzei; E. Mini
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT-11), infusional 5-fluorouracil/folinic acis (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT-11- or OHP-based CHT 2003 Mini E; Nobili S; Mazzocchi V; Del Buono S; Scicolone S; Giglioni B; Mazzei T
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (pts) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT 2004 Mini E.; Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Giglioni B; Mazzei T
Biweekly (BW) chemotherapy (CHT) with oxaliplatin (OHP), irinotecan (CPT11), infusional 5-fluorouracil/folinic acid (FU/FA) in patients (PTS) with metastatic colorectal cancer (MCRC) pretreated with CPT11- or OHP-based CHT. 2004 Nobili S; Del Buono S; Mazzocchi V; Filippelli F; Giglioni B; Mazzei T; Mini E
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 2003 Nobili S; Mazzocchi V; Del Buono S.; Scicolone S; Giglioni B; Mazzei T; Mini E
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 2021 Roncato, R.; Cecchini, E.; Dalle Fratte, C.; Decorti, G.; Del Re, M.; Franca, R.; Nobili, S.; Ravegnini, G.; Stocco, G.; Mini, E.; Toffoli, G.; Cancer Pharmacology Working Group, W.G.
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 2018 Lavacchi D, Nobili S, Brugia M, Paderi A, Fancelli S, Caliman E, Vergoni F, Mini E.
Cellular pharmacology of gemcitabine. 2006 E. Mini; S. Nobili; B. Caciagli; I. Landini; T. Mazzei
Chemioterapici Antimicrobici - Glicopeptidi 2010 Mini E.; Nobili S.; Novelli A.; Mazzei T
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 2014 Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C.
Chronic inflammation in urothelial bladder cancer 2015 Nesi, Gabriella; Nobili, Stefania; Cai, Tommaso; Caini, Saverio; Santi, Raffaella